Hemotune
Hemotune raised US$18.2M in Series B funding.
Email and contact information
Company website: www.hemotune.ch/
Decision maker info and email: SIGNUP TO UNBLOCK
Headquarters: Zürich, Zurich (Switzerland)
Industry: Biotechnology, Health Care, Life Science, Medical Device, Therapeutics
Business model:
Funding
- Total funding amount: $18,212,138 (in USD)
- Estimated valuation: $91,060,690.00
- Latest deal type: Series B
- First fundind year: 2022
Growth
Founders: Carlos Mora, Lukas Langenegger
Top investors: Venture Kick, Zürcher Kantonal Bank, OCCIDENT, EIT Health, Hemex
Team size: SIGNUP TO UNBLOCK
Revenue: SIGNUP TO UNBLOCK